Newsfiscal.ai
Maxim Group Maintains Buy Rating for Lucid Diagnostics
· Published
Article summary
Analyst Anthony Vendetti of Maxim Group LLC has reiterated a 'Buy' rating and a $2.00 price target for Lucid Diagnostics Inc. (LUCD).
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…